Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strattera in Children with ADHD and Poor Stimulant Response
NCT00181948Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Primary endpoints: Clinical Global Impression (ADHD) and ADHD Symptom Checklist. Started Sep 2004; status: completed.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00181948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181948.